Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Rivoltini

Showing results (31-40 of 82) with videos related to

Pageof 9
Sort By:
Cancer Research|November 1, 1995
Recognition of multiple epitopes in the human melanoma antigen gp100 by peripheral blood lymphocytes stimulated in vitro with synthetic peptidesM L Salgaller, A Afshar, F M Marincola, et al.
Cancer Research|May 1, 1988
Susceptibility of chemoresistant murine and human tumor cells to lysis by interleukin 2-activated lymphocytesC Gambacorti-Passerini, L Rivoltini, R Supino, et al.
International Journal of Cancer|August 5, 2000
Murine granulocytes control human tumor growth in SCID miceF Lozupone, F Luciani, M Venditti, et al.
Blood|May 15, 1993
Interleukin-6 expression in human neutrophil and eosinophil peripheral blood granulocytesC Melani, G F Mattia, A Silvani, et al.
Tumori|October 31, 1988
A new procedure for large scale production and freezing of lymphokine activated killer (LAK) cells to be used in adoptive immunotherapy of cancerC Gambacorti-Passerini, M Radrizzani, L Rivoltini, et al.
The International Journal of Biological Markers|January 1, 1993
Chronic effects of subcutaneous interleukin-2 therapy on soluble interleukin-2 receptors in advanced small cell lung cancerS Viviani, P M Salvini, P Bidoli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 8, 2021
Is impaired response to PD-1 blockers of high serum PD-1 patients related to immune complexes?E Daveri, E Luison, V Vallacchi, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Phenotypic and functional analysis of lymphocytes infiltrating paediatric tumours, with a characterization of the tumour phenotypeL Rivoltini, F Arienti, A Orazi, et al.
Cancer Immunology, Immunotherapy : CII|July 19, 2001
Simultaneous transduction of B7-1 and IL-2 genes into human melanoma cells to be used as vaccine: enhancement of stimulatory activity for autologous and allogeneic lymphocytesA Mazzocchi, C Melani, L Rivoltini, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 27, 1994
Human CD4+ T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase geneS L Topalian, L Rivoltini, M Mancini, et al.
Pageof 9

Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
Cancer Research|November 1, 1995
Recognition of multiple epitopes in the human melanoma antigen gp100 by peripheral blood lymphocytes stimulated in vitro with synthetic peptidesM L Salgaller, A Afshar, F M Marincola, et al.
Cancer Research|May 1, 1988
Susceptibility of chemoresistant murine and human tumor cells to lysis by interleukin 2-activated lymphocytesC Gambacorti-Passerini, L Rivoltini, R Supino, et al.
International Journal of Cancer|August 5, 2000
Murine granulocytes control human tumor growth in SCID miceF Lozupone, F Luciani, M Venditti, et al.
Blood|May 15, 1993
Interleukin-6 expression in human neutrophil and eosinophil peripheral blood granulocytesC Melani, G F Mattia, A Silvani, et al.
Tumori|October 31, 1988
A new procedure for large scale production and freezing of lymphokine activated killer (LAK) cells to be used in adoptive immunotherapy of cancerC Gambacorti-Passerini, M Radrizzani, L Rivoltini, et al.
The International Journal of Biological Markers|January 1, 1993
Chronic effects of subcutaneous interleukin-2 therapy on soluble interleukin-2 receptors in advanced small cell lung cancerS Viviani, P M Salvini, P Bidoli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 8, 2021
Is impaired response to PD-1 blockers of high serum PD-1 patients related to immune complexes?E Daveri, E Luison, V Vallacchi, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Phenotypic and functional analysis of lymphocytes infiltrating paediatric tumours, with a characterization of the tumour phenotypeL Rivoltini, F Arienti, A Orazi, et al.
Cancer Immunology, Immunotherapy : CII|July 19, 2001
Simultaneous transduction of B7-1 and IL-2 genes into human melanoma cells to be used as vaccine: enhancement of stimulatory activity for autologous and allogeneic lymphocytesA Mazzocchi, C Melani, L Rivoltini, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 27, 1994
Human CD4+ T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase geneS L Topalian, L Rivoltini, M Mancini, et al.
Pageof 9